Regulation of Wnt signaling target gene expression by the histone methyltransferase DOT1L

ACS Chemical Biology

Volumn 10, Issue 1, 2015, Pages 109-114

  Gibbons, Garrett S ^a   Owens, Scott R ^a   Fearon, Eric R ^a   Nikolovska Coleska, Zaneta ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISRUPTOR OF TELOMERIC SILENCING 1 LIKE; HISTONE METHYLTRANSFERASE; MIXED LINEAGE LEUKEMIA PROTEIN; UNCLASSIFIED DRUG; ADENOSINE; CARBANILAMIDE DERIVATIVE; DOT1L PROTEIN, HUMAN; ENZYME INHIBITOR; EPZ004777; HISTONE; LYSINE; METHYLTRANSFERASE;

ADENOCARCINOMA CELL LINE; ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE REARRANGEMENT; GENE TARGETING; HEK293 CELL LINE; HISTONE METHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; WNT SIGNALING PATHWAY; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; GENETICS; METABOLISM; METHYLATION; TUMOR CELL LINE;

ADENOSINE; CELL LINE, TUMOR; ENZYME INHIBITORS; GENE EXPRESSION; HEK293 CELLS; HISTONES; HUMANS; LYSINE; METHYLATION; METHYLTRANSFERASES; PHENYLUREA COMPOUNDS; WNT SIGNALING PATHWAY;

EID: 84921370808     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500668u     Document Type: Article

References (27)

1. Clevers, H. and Nusse, R. (2012) Wnt/beta-Catenin Signaling and Disease Cell 149, 1192-1205
2. Willert, K. and Jones, K. A. (2006) Wnt signaling: is the party in the nucleus? Genes Dev. 20, 1394-1404
3. Mosimann, C., Hausmann, G., and Basler, K. (2009) beta-Catenin hits chromatin: regulation of Wnt target gene activation Nat. Rev. Mol. Cell Biol. 10, 276-U257
4. Albert, M. and Helin, K. (2010) Histone methyltransferases in cancer Semin. Cell Dev. Biol. 21, 209-220
5. Muntean, A. G. and Hess, J. L. (2012) The Pathogenesis of Mixed-Lineage Leukemia Annu. Rev. Pathol.: Mech. Dis. 7, 283-301
6. Krivtsov, A. V. and Armstrong, S. A. (2007) MLL translocations, histone modifications and leukaemia stem-cell development Nat. Rev. Cancer 7, 823-833
7. Feng, Q., Wang, H. B., Ng, H. H., Erdjument-Bromage, H., Tempst, P., Struhl, K., and Zhang, Y. (2002) Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain Curr. Biol. 12, 1052-1058
8. Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., and Zhang, Y. (2005) hDOT1L links histone methylation to leukemogenesis Cell 121, 167-178
9. Shen, C. X., Jo, S. Y., Liao, C. Z., Hess, J. L., and Nikolovska-Coleska, Z. (2013) Targeting recruitment of Disruptor of Telomeric Silencing 1-like (DOT1L) characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion protiens J. Biol. Chem. 288, 30585-30596
10. Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y. H., Jin, L., Kuntz, K. W., Chesworth, R., Moyer, M. P., Bernt, K. M., Tseng, J. C., Kung, A. L., Armstrong, S. A., Copeland, R. A., Richon, V. M., and Pollock, R. M. (2011) Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor Cancer Cell 20, 53-65
11. Yu, W. Y., Smil, D., Li, F. L., Tempel, W., Fedorov, O., Nguyen, K. T., Bolshan, Y., Al-Awar, R., Knapp, S., Arrowsmith, C. H., Vedadi, M., Brown, P. J., and Schapira, M. (2013) Bromo-deaza-SAH: A potent and selective DOT1L inhibitor Bioorg. Med. Chem. 21, 1787-1794
12. Mohan, M., Herz, H. M., Takahashi, Y. H., Lin, C. Q., Lai, K. C., Zhang, Y., Washburn, M. P., Florens, L., and Shilatifard, A. (2010) Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom) Genes Dev. 24, 574-589
13. Mahmoudi, T., Boj, S. F., Hatzis, P., Li, V. S. W., Taouatas, N., Vries, R. G. J., Teunissen, H., Begthel, H., Korving, J., Mohammed, S., Heck, A. J. R., and Clevers, H. (2010) The Leukemia-Associated Mllt10/Af10-Dot1lAreTcf4/beta-Catenin Coactivators Essential for Intestinal Homeostasis PLoS Biol. 8, e1000539
14. Betancourt, M. C. C., Cailotto, F., Kerkhof, H. J., Cornelis, F. M. F., Doherty, S. A., Hart, D. J., Hofman, A., Luyten, F. P., Maciewicz, R. A., Mangino, M., Metrustry, S., Muir, K., Peters, M. J., Rivadeneira, F., Wheeler, M., Zhang, W. Y., Arden, N., Spector, T. D., Uitterlinden, A. G., Doherty, M., Lories, R. J. U., Valdes, A. M., and van Meurs, J. B. J. (2012) Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis Proc. Natl. Acad. Sci. U. S. A. 109, 8218-8223
15. Jo, S. Y., Granowicz, E. M., Maillard, I., Thomas, D., and Hess, J. L. (2011) Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation Blood 117, 4759-4768
16. Ho, L. L., Sinha, A., Verzi, M., Bernt, K. M., Armstrong, S., and Shivdasani, R. A. (2013) DOT1L-mediated H3K79 methylation in chromatin is dispensable for Wnt pathway-specific and other intestinal epithelial functions Mol. Cell. Biol. 33, 1735-1745
17. Korinek, V., Barker, N., Morin, P. J., vanWichen, D., deWeger, R., Kinzler, K. W., Vogelstein, B., and Clevers, H. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC(-/-) colon carcinoma Science 275, 1784-1787
18. Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., Mills, D., Brown, M. J., Haigh, D., Ward, R. W., Smith, D. G., Murray, K. J., Reith, A. D., and Holder, J. C. (2000) Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription ACS Chem. Biol. 7, 793-803
19. Hirsch, C., Campano, L. M., Wohrle, S., and Hecht, A. (2007) Canonical Wnt signaling transiently stimulates proliferation and enhances neurogenesis in neonatal neural progenitor cultures Exp. Cell Res. 313, 572-587
20. Li, V. S. W., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J. R., Maurice, M. M., Mahmoudi, T., and Clevers, H. (2012) Wnt Signaling through Inhibition of beta-Catenin Degradation in an Intact Axin1 Complex Cell 149, 1245-1256
21. Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., and Clevers, H. (2007) Identification of stem cells in small intestine and colon by marker gene Lgr5 Nature 449, 1003-U1001
22. van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A. P., Tion-Pon-Fong, M., Moerer, P., van den Born, M., Soete, G., Pals, S., Eilers, M., Medema, R., and Clevers, H. (2002) The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells Cell 111, 241-250
23. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W. (1998) Identification of c-MYC as a target of the APC pathway Science 281, 1509-1512
24. Jho, E. H., Zhang, T., Domon, C., Joo, C. K., Freund, J. N., and Costantini, F. (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway Mol. Cell. Biol. 22, 1172-1183
25. Ho, J. S. L., Ma, W. L., Mao, D. Y. L., and Benchimol, S. (2005) p53-dependent transcriptional repression of c-myc is required for G(1) cell cycle arrest Mol. Cell Biol. 25, 7423-7431
26. Mognol, G. P., de Araujo-Souza, P. S., Robbs, B. K., Teixeira, L. K., and Viola, J. P. B. (2012) Transcriptional regulation of the c-Myc promoter by NFAT1 involves negative and positive NFAT-responsive elements Cell Cycle 11, 1014-1028
27. Vartanian, R., Masri, J., Martin, J., Cloninger, C., Holmes, B., Artinian, N., Funk, A., Ruegg, T., and Gera, J. (2011) AP-1 Regulates Cyclin D1 and c-MYC Transcription in an AKT-Dependent Manner in Response to mTOR Inhibition: Role of AIP4/Itch-Mediated JUNB Degradation Mol. Cancer Res. 9, 115-130